[1]王建六.应科学理解子宫内膜癌的规范化治疗[J].郑州大学学报(医学版),2012,(01):1.
点击复制

应科学理解子宫内膜癌的规范化治疗
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2012年01期
页码:
1
栏目:
特约述评
出版日期:
2012-01-20

文章信息/Info

作者:
王建六
北京大学人民医院妇产科 北京 100004
关键词:
子宫内膜癌切除范围腹膜后淋巴结腹主动脉旁淋巴结内分泌治疗

参考文献/References:

[1]乐杰.妇产科学[M].7版.北京:人民卫生出版社,2008:275 [2]曹泽毅.妇科常见肿瘤诊治指南[M].3版.北京:人民卫生出版社,2010:54 [3]李小毛,梁常艳. 2009年版NCCN子宫内膜癌临床实践指南解读[J].广东医学,2009,30(11):1593 [4]Seamon LG, Fowler JM, Cohn DE. Lymphadenectomy for endometrial cancer: the controversy[J].Gynecol Oncol,2010,117(1):6 [5]吴婉莉,万小云,谢幸.Ⅰ期子宫内膜癌盆腔淋巴清扫术的意义[J].现代妇产科进展,2006,15(10):746 [6]Kitchener H, Swart AM, Qian Q, et al.Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study[J].Lancet,2009,373(9658):125 [7]吴玉梅,徐小红,张铁娟,等.分期手术治疗子宫内膜癌临床价值的探讨[J].北京医学,2005,27(1):25 [8]Guntupalli SR, Zighelboim I, Kizer NT,et al.Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer[J].Gynecol Oncol,2012,124(1):31 [9]Nomura H,Aoki D,Suzuki N, et al. Analysis of clinicopathologic factors predicting paraaortic lymph node metastasis in endometrial cancer[J].Int J Gynecol Cancer,2006,16(2):799 [10]Yaegashi N,Ito K,Niikura H.Lymphadenectomy for endometrial carcer is paraaortic lymphadenectomy necessary?[J].Int J Clin Oncol,2007,12(3):176 [11]von Minckwitz G,Loibl S,Brunnert K,et al.Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage Ⅰ and Ⅱ endometrial cancer:a multicentre, open, controlled, prospectively randomised trial[J].Eur J Cancer,2002,38(17):2265 [12]Vishnevsky AS,Bokhman YaV,Loutfi G.Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5year survival rate of surgical and combined treatment of primary endometrial carcinoma patients[J].Eur J Gynaecol Oncol,1993,14(2):150 [13]王志启,王建六, 魏丽惠. 辅助内分泌治疗对Ⅰ期子宫内膜癌疗效的临床观察[J].中国实用妇科与产科杂志,2006,22(11):824 [14]王建六.子宫内膜癌[M].北京:北京大学医学出版社,2010:209 [15]Erkanli S,Ayhan A. Fertilitysparing therapy in young women with endometrial cancer:2010 Update[J].Int J Gynecol Cancer,2010,20(7):1170 [16]Wheeler DT,Bristow RE,Kurman RJ.Histologic alterations in endometrial hyperplasia and welldifferentiated carcinoma treated with progestins[J].Am J Surg Pathol,2007,31(7):988

相似文献/References:

[1]王学博,乔玉环#,郭瑞霞,等.子宫内膜癌组织中包含WW域的氧化还原酶和脆性组氨酸三联体蛋白的表达[J].郑州大学学报(医学版),2010,(01):103.
 WANG Xuebo,QIAO Yuhuan,GUO Ruixia,et al.Expression of WW domain containing oxidoreductase and fragile histidine triad protein in endometrial carcinoma tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(01):103.
[2]乔玉环△,黄珊珊,郭瑞霞.17β雌二醇对Ishikawa细胞增殖及P21ras、pErk蛋白表达的影响[J].郑州大学学报(医学版),2009,(02):364.
 QIAO Yuhuan,HUANG Shanshan,GUO Ruixia.Effects of 17βestradiol on proliferation and expressions of P21ras and pErk in Ishikawa cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(01):364.
[3]李超,杨利霞#,甄艳华.子宫内膜癌经阴道彩色多普勒超声征象与微血管密度相关性分析[J].郑州大学学报(医学版),2009,(02):422.
 LI Chao,YANG Lixia,ZHEN Yanhua.Correlation between transvaginal color doppler sonography features and MVD in endometrial cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(01):422.
[4]邢庆娜△,张小安,赵鑫.磁共振弥散加权成像和动态增强成像在子宫内膜癌分期中的价值比较[J].郑州大学学报(医学版),2014,(01):113.
 XING Qingna,ZHANG Xiaoan,ZHAO Xin.Value comparison of diffusion weighted imaging with dynamic contrast enhanced imaging in staging of endometrial cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(01):113.
[5]王晓冬,程敬亮#,孙梦恬,等.3.0T MRI对Ⅰ期子宫内膜癌术前分期的诊断价值[J].郑州大学学报(医学版),2014,(02):240.
 WANG Xiaodong,CHENG Jingliang,SUN Mengtian,et al.Diagnostic value of 3.0 Tesla MRI for preoperative staging of stage Ⅰ endometrial carcinoma[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(01):240.
[6]郭琦,陈秀芹#,付建红,等.子宫内膜癌患者血清sTn抗原水平检测*[J].郑州大学学报(医学版),2014,(03):406.
[7]陈红敏△,窦蒙蒙,荣方方,等.子宫内膜癌腹膜后淋巴结转移及预后的相关因素分析[J].郑州大学学报(医学版),2015,(05):668.
 CHEN Hongmin,DOU Mengmeng,RONG Fangfang,et al.Influencing factors of retroperitoneal lymph node metastasis and prognosis of endometrial carcinoma[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(01):668.
[8]李灿灿,黄冬梅,孙欣欣,等.两种示踪剂在子宫内膜癌前哨淋巴结活检中的应用[J].郑州大学学报(医学版),2019,(01):64.[doi:10.13705/j.issn.1671-6825.2018.07.001]
 LI Cancan,HUANG Dongmei,SUN Xinxin,et al.Application of two tracers in sentinel lymph node biopsy of endometrial cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(01):64.[doi:10.13705/j.issn.1671-6825.2018.07.001]
[9]王晓华),李 辉),李 俊),等.下调SIRT1表达对子宫内膜癌细胞增殖及凋亡的影响[J].郑州大学学报(医学版),2019,(02):213.[doi:10.13705/j.issn.1671-6825.2018.08.077]
 WANG Xiaohua),LI Hui),LI Jun),et al.Effects of down-regulation of SIRT1 expression on proliferation and apoptosis of endometrial cancer cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(01):213.[doi:10.13705/j.issn.1671-6825.2018.08.077]
[10]王 慧),耿 玲),郭 威),等.上调miR-15a表达对子宫内膜癌细胞增殖、凋亡和NOB1蛋白表达的影响[J].郑州大学学报(医学版),2019,(06):840.[doi:10.13705/j.issn.1671-6825.2019.06.031]
 WANG Hui),GENG Ling),GUO Wei),et al.Effects of up-regulating miR-15a on proliferation, apoptosis and NOB1 expression of endometrial carcinoma cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(01):840.[doi:10.13705/j.issn.1671-6825.2019.06.031]

备注/Memo

备注/Memo:
王建六,1965年12月生,蒙族,医学博士, 妇产科教授,博士研究生导师。北京大学妇产科学系副主任,北京大学人民医院妇产科副主任、妇产科教研室主任。从事妇产科学医、教、研工作20余年,重点研究子宫颈癌、子宫内膜癌、卵巢癌以及子宫脱垂、尿失禁等疾病的诊断与治疗。任中华医学会妇产科学分会委员兼秘书, 全国女性盆底疾病学组副组长,中华医学会妇科肿瘤分会青年委员会常务副主任委员,中国医师协会妇产科学分会委员,中国抗癌协会妇瘤专业委员会常务委员。担任《中国妇产科临床杂志》副主编和《中华妇产科杂志》、《中国实用妇科与产科杂志》、《实用妇产科杂志》、《现代妇产科进展》等杂志编委。曾获霍英东基金会教师奖和卫生部优秀科研人才、北京市百名优秀青年医师等称号。承担国家级及省部级课题16项,发表论文180余篇,获省部级科技成果5项。 doi:10.3969/j.issn.16716825.2012.01.001
更新日期/Last Update: 1900-01-01